TY  - GEN
AU  - Hirsh,Vera
AU  - Major,Pierre P
AU  - Lipton,Allan
AU  - Cook,Richard J
AU  - Langer,Corey J
AU  - Smith,Matthew R
AU  - Brown,Janet E
AU  - Coleman,Robert E
TI  - Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity
SN  - 1556-1380
PY  - 2008///0522
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Alkaline Phosphatase
KW  - blood
KW  - Biomarkers, Tumor
KW  - urine
KW  - Bone Density Conservation Agents
KW  - administration & dosage
KW  - Bone Neoplasms
KW  - Canada
KW  - epidemiology
KW  - Carcinoma, Non-Small-Cell Lung
KW  - metabolism
KW  - Collagen Type I
KW  - drug effects
KW  - Diphosphonates
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Imidazoles
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Osteoclasts
KW  - Peptides
KW  - Retrospective Studies
KW  - Time Factors
KW  - Treatment Outcome
KW  - United States
KW  - Zoledronic Acid
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/JTO.0b013e3181651c0e
ER  -